×
About 18,792 results

ALLMedicine™ Neutropenia Center

Research & Reviews  8,757 results

Use of granulocyte transfusion in early period in life-threatening infections of pediat...
https://doi.org/10.1016/j.transci.2021.103134
Transfusion and Apheresis Science : Official Journal of T... Koc BS, Tekkesin F et. al.

Apr 16th, 2021 - Despite all the developments in medicine, infections continue to be one of the most important causes of mortality in pediatric hematology and oncology patients. The more severe the degree of neutropenia develops after intensive chemotherapy in can...

Usage of Plasma Presepsin, C-Reactive Protein, Procalcitonin and Proadrenomedullin to P...
https://doi.org/10.1093/labmed/lmab002
Laboratory Medicine; Arıkan K, Karadag-Oncel E et. al.

Apr 14th, 2021 - To investigate the value of presepsin and proadrenomedullin (proADM) as new markers for febrile neutropenia, by comparing them with conventional markers. Plasma specimens for presepsin, proADM, C-reactive protein (CRP), and procalcitonin (PCT) wer...

Complex Abdominal Wall Reconstruction in Neutropenic Patients.
https://doi.org/10.1177/00031348211011086
The American Surgeon; Agon K, Abbas S et. al.

Apr 13th, 2021 - The aim of our study was to determine whether patients with neutropenia (absolute neutrophil count (ANC) ≤1,500 cells/µL) had higher rates of surgical site infection after elective abdominal wall reconstruction. This was a case series from a prosp...

Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for ...
https://doi.org/10.4143/crt.2021.010
Cancer Research and Treatment; Lee JW, Bae JS et. al.

Apr 13th, 2021 - We performed this study to determine whether the degree of neutropenia after the first chemotherapy cycle can be used as a surrogate marker of individual susceptibility to chemotherapeutic agents affecting treatment outcome in patients with neurob...

see more →

Guidelines  57 results

Emerging challenges in the evaluation of fever in cancer patients at risk of febrile ne...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682766
Supportive Care in Cancer : Official Journal of the Multi... Cooksley T, Font C et. al.

Nov 24th, 2020 - Patients with cancer are at higher risk of more severe COVID-19 infection and have more associated complications. The position paper describes the management of cancer patients, especially those receiving anticancer treatment, during the COVID-19 ...

Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism.
https://doi.org/10.1210/clinem/dgaa543
The Journal of Clinical Endocrinology and Metabolism; Brar PC, Heksch R et. al.

Aug 18th, 2020 - The diagnosis of hypoglycemia and the use of diazoxide have risen in the last decade. Diazoxide is the only Food and Drug Agency-approved pharmacologic treatment for neonatal hypoglycemia caused by hyperinsulinism (HI). Recent publications have hi...

Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by t...
https://www.idsociety.org/globalassets/idsa/practice-guidelines/2019-asymptomatic-bacteriuria.pdf

Mar 20th, 2019 - Asymptomatic bacteriuria (ASB) is a common finding in many populations, including healthy women and persons with underlying urologic abnormalities. The 2005 guideline from the Infectious Diseases Society of America recommended that ASB should be s.

ACR Appropriateness Criteria® Acute Nonlocalized Abdominal Pain.
https://doi.org/10.1016/j.jacr.2018.09.010
Journal of the American College of Radiology : JACR; , Scheirey CD et. al.

Nov 5th, 2018 - The range of pathology in adults that can produce abdominal pain is broad and necessitates an imaging approach to evaluate many different organ systems. Although localizing pain prompts directed imaging/management, clinical presentations may vary ...

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update
http://ascopubs.org/doi/full/10.1200/JCO.18.00374
Taplitz,R.,et al

Sep 3rd, 2018 - Antibacterial and antifungal prophylaxis is recommended for patients who are at high risk of infection, including patients who are expected to have profound, protracted neutropenia, which is defined as < 100 neutrophils/µL for > 7 days or other ri...

see more →

Drugs  247 results see all →

Clinicaltrials.gov  9,299 results

Use of granulocyte transfusion in early period in life-threatening infections of pediat...
https://doi.org/10.1016/j.transci.2021.103134
Transfusion and Apheresis Science : Official Journal of T... Koc BS, Tekkesin F et. al.

Apr 16th, 2021 - Despite all the developments in medicine, infections continue to be one of the most important causes of mortality in pediatric hematology and oncology patients. The more severe the degree of neutropenia develops after intensive chemotherapy in can...

Usage of Plasma Presepsin, C-Reactive Protein, Procalcitonin and Proadrenomedullin to P...
https://doi.org/10.1093/labmed/lmab002
Laboratory Medicine; Arıkan K, Karadag-Oncel E et. al.

Apr 14th, 2021 - To investigate the value of presepsin and proadrenomedullin (proADM) as new markers for febrile neutropenia, by comparing them with conventional markers. Plasma specimens for presepsin, proADM, C-reactive protein (CRP), and procalcitonin (PCT) wer...

Complex Abdominal Wall Reconstruction in Neutropenic Patients.
https://doi.org/10.1177/00031348211011086
The American Surgeon; Agon K, Abbas S et. al.

Apr 13th, 2021 - The aim of our study was to determine whether patients with neutropenia (absolute neutrophil count (ANC) ≤1,500 cells/µL) had higher rates of surgical site infection after elective abdominal wall reconstruction. This was a case series from a prosp...

Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for ...
https://doi.org/10.4143/crt.2021.010
Cancer Research and Treatment; Lee JW, Bae JS et. al.

Apr 13th, 2021 - We performed this study to determine whether the degree of neutropenia after the first chemotherapy cycle can be used as a surrogate marker of individual susceptibility to chemotherapeutic agents affecting treatment outcome in patients with neurob...

see more →

News  431 results

Convenience, Cost Sway Choice of G-CSF Added to Chemo
https://www.medscape.com/viewarticle/945109

Feb 1st, 2021 - The choice of whether to use granulocyte colony-stimulating factor (G-CSF) for the prevention of febrile neutropenia for patients undergoing chemotherapy depends on whether it is being used for primary or secondary prophylaxis, indicates a survey ...

Fast Five Quiz: Myelodysplastic Syndrome
https://reference.medscape.com/viewarticle/943967

Jan 27th, 2021 - Myelodysplastic syndrome (MDS) is a group of related hematopoietic disorders characterized by peripheral blood cytopenias, abnormal blood cell development, and clonal genetic markers. Patients with MDS may present with clinical manifestations of a...

'Major Advancement' in Preventing Neutropenia, Says Trialist
https://www.medscape.com/viewarticle/944603

Jan 24th, 2021 - In the United States, for the past two decades, pegfilgrastim (Neulasta) and its biosimilars have been the widely used standard of care for the prevention of chemotherapy-induced neutropenia (CIN). Now, the champions of a new agent, plinabulin (Be...

Late-Onset Neutropenia More Common Than Expected in Patients on Rituximab
https://www.medscape.com/viewarticle/937807

Sep 21st, 2020 - A new study has found that late-onset neutropenia is a notably common and occasionally serious occurrence in rituximab-treated patients with autoimmune diseases. Dr. Reza Zonozi "The literature on late-onset neutropenia – or LON – has, to date, be...

Skin Lesions and Neutropenic Fever in a 69-Year-Old Woman
https://reference.medscape.com/viewarticle/932875

Jun 25th, 2020 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

see more →

Patient Education  1 results see all →